Zhejiang Qianjiang Biochemical Co., Ltd Class A

Zhejiang Qianjiang Biochemical Co., Ltd Class A

SSSE:600796
4.69
CNY
-0.01
(-0.21%)
0.16EPS
31.30P/E
4.43BMarket Cap
2013 Y
2014 Y
2015 Y
2016 Y
2017 Y
2018 Y
2019 Y
2020 Y
2021 Y
2022 Y
2023 Y
2024 Y
2025 Y
TTM
Revenue per Share
1.57
1.24
1.61
1.49
1.6
1.49
1.19
2.95
3.02
2.34
2.32
1.99
1.93
1.84
Basic EPS, GAAP
0.1
0.07
0.09
0.11
0.14
-0.15
0.06
0.15
0.22
0.24
0.24
0.18
0.19
0.16
Free Cash Flow per Basic Share
0.09
0.09
0.06
-0.03
0.09
0.02
0.03
0.07
-0.3
0.04
0.13
-0.5
0.2
- -
Dividend per Share
0.07
0.08
0.04
0.03
0.07
0.05
0.01
0.11
0.12
0.23
0.2
0.11
0.11
0.07
Book Value per Share
1.77
1.81
1.9
2.01
2.1
1.92
1.98
6.18
3.34
3.48
3.62
3.78
3.97
4.09
Tangible Book Value per Share
1.67
1.73
1.82
1.93
2.01
1.83
1.9
-2.5
0.31
0.4
0.57
0.26
0.07
0.53
Basic Weighted Avg Shares
306
320
295
298
293
298
320
641
672
859
878
889
876
879
Sales/Revenue/Turnover
482
398
474
444
468
443
380
1,888
2,031
2,009
2,034
1,768
1,694
1,620
Operating Margin (%)
9.39
5.39
11.22
10.05
9.6
1.78
10.07
15.41
15.06
13.58
14.07
12.22
14.38
15.59
Depreciation Expense
36
38
42
44
44
45
44
166
183
236
225
234
193
- -
Net Income, GAAP
31
22
27
33
41
-45
19
96
148
206
211
160
166
143
Effective Tax Rate (%)
17.22
16.73
18.75
14.8
8.86
- -
13.61
29.67
22.4
20.88
20.08
28.1
22.72
15.95
Profit Margin (%)
6.36
5.62
5.6
7.39
8.77
-10.08
5.04
5.09
7.28
10.26
10.36
9.05
9.82
8.85
Working Capital
42
167
211
211
182
209
247
-134
422
588
386
744
521
669
LT Debt
- -
- -
- -
- -
- -
- -
- -
964
1,292
1,363
975
1,741
1,403
1,222
Total Equity
552
567
597
635
664
613
634
2,479
3,304
3,402
3,497
3,557
3,705
3,810
Return on Invested Capital (%)
2.35
1.32
3.33
2.89
6.52
- -
4.08
5.23
3.59
3.68
3.49
2.13
2.73
- -
Return on Capital (%)
5.54
4.05
3.94
4.11
5.06
- -
2.12
3.06
4.17
5.6
5.83
4.47
3.84
- -
Return on Common Equity (%)
5.92
4.15
4.75
5.57
6.63
-7.38
3.26
7.82
6.22
6.98
6.85
4.99
4.95
- -

Capital Structure

CNY

•

in mil. unless spec.
Mar'26
Jun'26
Sep'26
ST Debt
410
423
473
LT Borrowings
1,400
1,344
1,221
LT Finance Leases
2
- -
1
Preferred Equity and Hybrid Capital
- -
- -
- -
Shares Outstanding
867
867
867
Market Capitalization
5,711
4,021
4,428

Working Capital

CNY

•

in mil. unless spec.
Mar'26
Jun'26
Sep'26
Total Current Assets
2,174
2,203
2,283
Cash, Cash Equivalents & STI
855
864
886
Accounts Receivable, Net
760
895
956
Inventories
168
168
183
Total Current Liabilities
1,491
1,614
1,613
Payables & Accruals
- -
- -
- -
ST Debt
410
423
473
Deferred Revenue
- -
- -
- -

Growth Rates

CNY

•

in mil. unless spec.

(avg. rate of change)

10 years
5 years
1 year
Total Equity
34.26%
8.98%
4.17%
Free Cash Flow
-122.24%
-203.18%
-140.09%
Net Income, GAAP
17.33%
15.07%
3.98%
Sales/Revenue/Turnover
36.65%
-1.91%
-4.22%
Total Cash Common Dividend
210.85%
20.9%
-3.35%

Quarterly Revenue

CNY

•

in mil. unless spec.

Year

Q1
Q2
Q3
Q4
FY
2024
374
489
438
468
1,768
2025
378
402
- -
495
1,694
2026
319
415
392
- -
- -

Quarterly Earnings Per Share

CNY

•

in mil. unless spec.

Year

Q1
Q2
Q3
Q4
FY
2024
0.03
0.06
0.05
0.04
0.18
2025
0.04
0.09
- -
0.02
0.19
2026
0.04
0.05
0.06
- -
- -

Quarterly Dividends Per Share

CNY

•

in mil. unless spec.

Year

Q1
Q2
Q3
Q4
FY
2024
0.02
0.06
0.03
0.01
0.11
2025
- -
0.05
- -
- -
0.11
2026
0.01
0.03
0.02
- -
- -

Company Description

CEO
Yu Chao Sun
Full Time Employees
1,809
Sector
Process industries
Industry
Chemicals: agricultural
Address
Qianjiang Building Haining ZJ China 314400
IPO Date
Apr 8, 1997
Website
600796.com
Business
Zhejiang Qianjiang Biochemical Co., Ltd, founded in 1997 and headquartered in Zhejiang, China, operates primarily in the chemical and biochemical industry specializing in biopesticides, bio-veterinary medicines, and biological pharmaceuticals. The company produces and sells a diverse range of biologically based products including biopesticides consisting of plant growth regulators such as gibberellic acid and gibberellic acid A4+A7; insecticides including abamectin, methylamino abamectin, and avermectin; bactericides like the Jinggangmycin series and proconazole; biological drugs including colistin sulfate premix and related intermediates; and feed additives. It also offers environmental treatment services covering water supply, sewage treatment, solid and hazardous waste landfill and incineration, and food waste disposal. The company distributes its products primarily within China but maintains an international sales network covering Europe, Asia, South America, and Southeast Asia. Recent major developments include a significant capital infusion from Haining Water Investment Group amounting to approximately CNY 356 million aimed at supporting new facility construction and operational optimization. Zhejiang Qianjiang is undergoing a major assets reorganization involving land resumption and industrial upgrading facilitated by collaborations with state-owned entities in the Haining Economic Development Zone. These strategic partnerships and facility expansions underscore its ongoing business transformation towards enhanced production capacity and advanced technology application. The company continues to leverage its proprietary research capabilities, including personalized microbial technology systems, to drive innovation in agricultural and veterinary biochemical products. Zhejiang Qianjiang Biochemical stands as a key player in China's bio-based chemical industry, recognized for its advanced production technology and a robust technical and R&D infrastructure. It maintains a comprehensive product portfolio and a strategic focus on environmentally sustainable solutions alongside its biochemical product lines, catering primarily to agriculture, veterinary medicine, environmental management, and related industrial sectors. The company remains publicly listed with its shares traded on the Shanghai Stock Exchange (Ticker: 600796.SS). It employs over 2,000 staff and consistently pursues technological and operational enhancements aimed at long-term sustainable growth and shareholder value creation.